You are here: Home » Companies » News
Business Standard

Cadila Healthcare receives US FDA approval for schizophrenia drug

The product will be manufactured at Liva Pharma's manufacturing facility at Vadodara

Press Trust of India  |  New Delhi 

Cadila Healthcare, Moraiya
File photo of Cadila Healthcare's Moraiya facility

Drug firm on Thursday said it has received approval from the USFDA for Haloperidol Decanoate injection used in treatment of

The product will be manufactured at Liva Pharma's manufacturing facility at Vadodara, said in a BSE filing.

Haloperidol is used in the treatment of and for the control of tics and vocal utterances of Tourette syndrome.

First Published: Thu, October 24 2019. 11:40 IST
RECOMMENDED FOR YOU